Literature DB >> 27301509

Primary Poorly Differentiated Squamous Cell Carcinoma of the Extrahepatic Bile Duct.

Takuma Goto1, Junpei Sasajima, Kazuya Koizumi, Yoshiaki Sugiyama, Toru Kawamoto, Shugo Fujibayashi, Kentaro Moriichi, Masataka Yamada, Mikihiro Fujiya, Yutaka Kohgo.   

Abstract

Squamous cell carcinoma of the extrahepatic bile duct is quite rare. A 77-year-old woman with jaundice and general fatigue was referred to our hospital. Multiphase contrast-enhanced computed tomography visualized a 17-mm solid mass in the junction of the cystic and common bile ducts. The patient underwent pylorus-preserving pancreaticoduodenectomy. The pathological findings demonstrated keratin-positive poorly differentiated squamous cell carcinoma of the extrahepatic bile duct (T3N0M0, stage IIIA). Although adjuvant chemotherapy with gemcitabine was administered, the patient exhibited local recurrence at the site of anastomosis of biliojejunostomy 20 months after resection and died 32 months after resection.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27301509     DOI: 10.2169/internalmedicine.55.6226

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Squamous cell carcinoma of the extrahepatic bile duct with metachronous para-aortic lymph node metastasis successfully treated with S-1 plus cisplatin.

Authors:  Ryohei Nishiguchi; Dal Ho Kim; Masayuki Honda; Tsuguo Sakamoto
Journal:  BMJ Case Rep       Date:  2016-12-08

2.  PRIMARY SQUAMOUS CELL CARCINOMA OF THE COMMON BILE DUCT WITH LIVER METASTASES.

Authors:  Dhouha Bacha; Mohamed Hajri; Wael Ferjaoui; Ghofrane Talbi; Lasaad Gharbi; Mohamed Taher Khalfallah; Sana Ben Slama; Ahlem Lahmar
Journal:  Arq Bras Cir Dig       Date:  2021-05-14

3.  Primary congenital choledochal cyst with squamous cell carcinoma: a case report.

Authors:  Lili Wang; Xiaomei Ma; Dongdong Chen; Jialiang Ren; Hua Cheng; Gang Huang; Rong Wang; Jiarong Cheng
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.